Sunesis Pharmaceuticals to Report 2005 Financial Results on March 24, 2006
March 17 2006 - 8:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., March 17 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), a clinical-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel small molecule therapeutics, today
announced that Sunesis senior management will hold an investor
conference call to discuss 2005 fourth-quarter and year-end
financial results on Friday, March 24, 2006 at 7:30 a.m. PST/10:30
a.m. EST. Individual and institutional investors can access the
call via 800-811-0667 (domestic) or 913-981-4901 (international).
To access the live audio broadcast or the subsequent archived
recording, visit the "Investors and Media -- Calendar of Events"
section of the Sunesis website at http://www.sunesis.com/ . Please
log on to Sunesis' website several minutes prior to the start of
the presentation to ensure adequate time for any software download
that may be necessary. About Sunesis Pharmaceuticals Sunesis is a
clinical-stage biopharmaceutical company focused on the discovery,
development and commercialization of novel small molecule
therapeutics for oncology and other serious diseases. Sunesis has
built a broad product candidate portfolio through internal
discovery and in-licensing of novel cancer therapeutics. Sunesis is
advancing its product candidates through in-house research and
development efforts and strategic collaborations with leading
pharmaceutical and biopharmaceutical companies. For further
information on Sunesis Pharmaceuticals, please visit
http://www.sunesis.com/ . Safe Harbor Statement This press release
contains forward-looking statements that involve substantial risks
and uncertainties. Sunesis may not actually achieve the plans,
intentions or expectations contained in such forward-looking
statements. Actual results or events could differ materially from
the plans, intentions and expectations contained in such
forward-looking statements. Sunesis does not assume any obligation
to update any such forward-looking statements. DATASOURCE: Sunesis
Pharmaceuticals, Inc. CONTACT: investors, Eric Bjerkholt, CFO of
Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or media, Karen L.
Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both
of BCC Partners, for Sunesis Pharmaceuticals, Inc. Web site:
http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024